Literature DB >> 2117140

Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections.

D Nadal1, P L Ogra.   

Abstract

The bronchus associated lymphoid tissue (BALT) and the precursor immunocompetent lymphoid cells in the nasopharynx, tonsils, and salivary glands represent the basic source of specific secretory IgA, other immunoglobulin, and T cell mediated specific immunity in the respiratory tract. The bulk of this immunologic reactivity is derived largely from BALT, and via the migration of antigen-sensitized immunocompetent cells, from the gut associated lymphoid tissues (GALT). Recent investigations have suggested that mechanisms underlying the development of virus-induced bronchopulmonary diseases, notably bronchospasm, include host factors such as altered immune response with persistent virus-specific IgE and IgG4 antibody responses in the respiratory tract, the appearance of specific immune complexes, and development of exaggerated immune response to other environmental agents and dietary proteins. In addition, pathogen related factors responsible for direct tissue damage during infection also play an important role.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117140     DOI: 10.1007/bf02718155

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  27 in total

1.  Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.

Authors:  P L Ogra; D T Karzon; F Righthand; M MacGillivray
Journal:  N Engl J Med       Date:  1968-10-24       Impact factor: 91.245

2.  Epidemiology of acute lower respiratory disease in children.

Authors:  P Glezen; F W Denny
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

3.  An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Authors:  A Z Kapikian; R H Mitchell; R M Chanock; R A Shvedoff; C E Stewart
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

4.  Secretory antibody response to respiratory syncytial virus infection.

Authors:  T N Kaul; R C Welliver; D T Wong; R A Udwadia; K Riddlesberger; P L Ogra
Journal:  Am J Dis Child       Date:  1981-11

5.  Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens.

Authors:  J Freihorst; P A Piedra; Y Okamoto; P L Ogra
Journal:  Proc Soc Exp Biol Med       Date:  1988-06

6.  Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy.

Authors:  E Leibovitz; J Freihorst; P A Piedra; P L Ogra
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

7.  Defective regulation of immune responses in respiratory syncytial virus infection.

Authors:  R C Welliver; T N Kaul; M Sun; P L Ogra
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

8.  Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease.

Authors:  R C Welliver; A Kaul; P L Ogra
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

9.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

10.  Development of allergy in children. I. Association with virus infections.

Authors:  O L Frick; D F German; J Mills
Journal:  J Allergy Clin Immunol       Date:  1979-04       Impact factor: 10.793

View more
  4 in total

Review 1.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

2.  Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection.

Authors:  H Yamazaki; H Tsutsumi; K Matsuda; K Nagai; P L Ogra; S Chiba
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

Review 3.  Potential therapeutic implications of new insights into respiratory syncytial virus disease.

Authors:  Peter J M Openshaw
Journal:  Respir Res       Date:  2002

4.  Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease.

Authors:  Chris J Carter
Journal:  J Alzheimers Dis Rep       Date:  2017-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.